SG10201510402WA - Bifunctional molecules with antibody-recruiting and entry inhibitory activity against the human immunodeficiency virus - Google Patents
Bifunctional molecules with antibody-recruiting and entry inhibitory activity against the human immunodeficiency virusInfo
- Publication number
- SG10201510402WA SG10201510402WA SG10201510402WA SG10201510402WA SG10201510402WA SG 10201510402W A SG10201510402W A SG 10201510402WA SG 10201510402W A SG10201510402W A SG 10201510402WA SG 10201510402W A SG10201510402W A SG 10201510402WA SG 10201510402W A SG10201510402W A SG 10201510402WA
- Authority
- SG
- Singapore
- Prior art keywords
- recruiting
- antibody
- inhibitory activity
- activity against
- immunodeficiency virus
- Prior art date
Links
- 241000725303 Human immunodeficiency virus Species 0.000 title 1
- 230000001588 bifunctional effect Effects 0.000 title 1
- 230000002401 inhibitory effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Dermatology (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US41497710P | 2010-11-18 | 2010-11-18 | |
| US201161522518P | 2011-08-11 | 2011-08-11 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG10201510402WA true SG10201510402WA (en) | 2016-01-28 |
Family
ID=46084646
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG10201510402WA SG10201510402WA (en) | 2010-11-18 | 2011-11-17 | Bifunctional molecules with antibody-recruiting and entry inhibitory activity against the human immunodeficiency virus |
| SG2013038344A SG190829A1 (en) | 2010-11-18 | 2011-11-17 | Bifunctional molecules with antibody-recruiting and entry inhibitory activity against the human immunodeficiency virus |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG2013038344A SG190829A1 (en) | 2010-11-18 | 2011-11-17 | Bifunctional molecules with antibody-recruiting and entry inhibitory activity against the human immunodeficiency virus |
Country Status (16)
| Country | Link |
|---|---|
| US (5) | US9562038B2 (en) |
| EP (1) | EP2640720B1 (en) |
| JP (2) | JP6155193B2 (en) |
| KR (1) | KR20140000275A (en) |
| CN (2) | CN103402998B (en) |
| AU (1) | AU2011329829B2 (en) |
| BR (1) | BR112013012309A2 (en) |
| CA (1) | CA2818308A1 (en) |
| CL (1) | CL2013001429A1 (en) |
| CO (1) | CO6801635A2 (en) |
| EA (1) | EA201390726A1 (en) |
| IL (1) | IL226397B (en) |
| MX (1) | MX350974B (en) |
| PE (1) | PE20140406A1 (en) |
| SG (2) | SG10201510402WA (en) |
| WO (1) | WO2012068366A2 (en) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT1423376E (en) | 2001-08-08 | 2010-04-12 | Tobira Therapeutics Inc | Bicyclic compound, production and use thereof |
| WO2011046946A2 (en) * | 2009-10-13 | 2011-04-21 | Yale University | Bifunctional molecules with antibody-recruiting and entry inhibitory activity against the human immunodeficiency virus |
| SG10201510402WA (en) | 2010-11-18 | 2016-01-28 | Univ Yale | Bifunctional molecules with antibody-recruiting and entry inhibitory activity against the human immunodeficiency virus |
| WO2013070688A1 (en) | 2011-11-11 | 2013-05-16 | Yale University | Reprogramming urokinase into an antibody-recruiting anticancer agent |
| EP2841107B1 (en) | 2012-04-26 | 2021-11-03 | Yale University | Cytotoxic-drug delivering molecules targeting hiv (cdm-hs), cytotoxic activity against the human immunodeficiency virus and methods of use |
| WO2013166110A1 (en) | 2012-05-02 | 2013-11-07 | Yale University | Tlr-agonist-conjugated antibody recruiting molecules (tlr_arms) |
| US10117943B2 (en) | 2013-05-03 | 2018-11-06 | Yale University | Synthetic antibody mimetic compounds (SYAMS) targeting cancer, especially prostate cancer |
| CN107207538A (en) | 2014-12-23 | 2017-09-26 | 妥必徕疗治公司 | The method for preparing CENICRIVIROC and related analogs |
| WO2017023994A1 (en) | 2015-08-06 | 2017-02-09 | Yale University | Small molecule based antibody-recruiting compounds for cancer treatment |
| HUE056243T2 (en) | 2015-12-15 | 2022-02-28 | Gilead Sciences Inc | Human immunodeficiency virus neutralizing antibodies |
| KR102471267B1 (en) * | 2016-03-18 | 2022-11-29 | 럿거스, 더 스테이트 유니버시티 오브 뉴저지 | Methods of targeting tumor cells using chemotherapeutic agents conjugated to anti-Matriptase antibodies by in vivo cleavable linking moieties |
| RU2019101242A (en) | 2016-06-21 | 2020-07-21 | Тобира Терапьютикс, Инк. | PURIFIED CENICRIVER AND CLEANED INTERMEDIATE CONNECTIONS FOR OBTAINING CENICRIVER |
| WO2018026997A1 (en) | 2016-08-03 | 2018-02-08 | Yale University | Antibody-recruiting molecules for the treatment of cancer |
| MX2019002057A (en) | 2016-08-31 | 2019-11-18 | Tobira Therapeutics Inc | Solid forms of cenicriviroc mesylate and processes of making solid forms of cenicriviroc mesylate. |
| CN107056762B (en) * | 2016-12-22 | 2020-08-28 | 四川百利药业有限责任公司 | Bis-carbonyl analogues for use against influenza virus |
| TWI728250B (en) | 2017-06-21 | 2021-05-21 | 美商基利科學股份有限公司 | Multispecific antibodies that target hiv gp120 and cd3 |
| CN113197912B (en) * | 2020-01-30 | 2023-02-03 | 沈阳福洋医药科技有限公司 | Isovaleryl spiramycin compound and application of isovaleryl spiramycin compound composition in preparation of antiviral drugs |
| CN111995622B (en) * | 2020-08-20 | 2022-04-15 | 复旦大学 | Compound and use thereof |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4522811A (en) | 1982-07-08 | 1985-06-11 | Syntex (U.S.A.) Inc. | Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides |
| ZA893284B (en) * | 1988-05-04 | 1990-03-28 | Igen Inc | Peptide analogs and their use as haptens to elicit catalytic antibodies |
| CA2134239C (en) * | 1992-06-09 | 2004-11-23 | Donald B. Axworthy | Pretargeting methods and compounds |
| JP3319073B2 (en) * | 1993-08-24 | 2002-08-26 | 和光純薬工業株式会社 | Immunological measurement method |
| US6140505A (en) * | 1995-03-10 | 2000-10-31 | G. D. Searle & Co. | Synthesis of benzo fused heterocyclic sulfonyl chlorides |
| US6469006B1 (en) * | 1999-06-15 | 2002-10-22 | Bristol-Myers Squibb Company | Antiviral indoleoxoacetyl piperazine derivatives |
| US6573262B2 (en) * | 2000-07-10 | 2003-06-03 | Bristol-Myers Sqibb Company | Composition and antiviral activity of substituted indoleoxoacetic piperazine derivatives |
| JP2004502768A (en) * | 2000-07-10 | 2004-01-29 | ブリストル−マイヤーズ スクイブ カンパニー | Composition and antiviral activity of substituted indole oxoacetic piperazine derivatives |
| US6825201B2 (en) * | 2001-04-25 | 2004-11-30 | Bristol-Myers Squibb Company | Indole, azaindole and related heterocyclic amidopiperazine derivatives |
| HUP0401523A3 (en) * | 2004-07-29 | 2007-05-02 | Richter Gedeon Vegyeszet | Indole-2-carboxamide derivatives, pharmaceutical compositions containing them and process for producing them |
| EP2444807B1 (en) * | 2006-11-01 | 2014-06-11 | Ventana Medical Systems, Inc. | Mono- and dinitropyrazole hapten conjugates |
| HUE025618T2 (en) * | 2008-05-13 | 2016-04-28 | Univ Yale | Chimeric small molecules for the recruitment of antibodies to cancer cells |
| EP2318051A4 (en) * | 2008-07-14 | 2012-12-26 | Andrew Metters | In vitro diagnostic markers comprising carbon nanoparticles and kits |
| JP2012517447A (en) * | 2009-02-10 | 2012-08-02 | ザ スクリプス リサーチ インスティチュート | Chemically programmed vaccination methods |
| WO2011046946A2 (en) * | 2009-10-13 | 2011-04-21 | Yale University | Bifunctional molecules with antibody-recruiting and entry inhibitory activity against the human immunodeficiency virus |
| EP2601174B1 (en) * | 2010-08-06 | 2014-11-26 | Bristol-Myers Squibb Company | Substituted indole and azaindole oxoacetyl piperazinamide derivatives |
| SG10201510402WA (en) | 2010-11-18 | 2016-01-28 | Univ Yale | Bifunctional molecules with antibody-recruiting and entry inhibitory activity against the human immunodeficiency virus |
-
2011
- 2011-11-17 SG SG10201510402WA patent/SG10201510402WA/en unknown
- 2011-11-17 BR BR112013012309A patent/BR112013012309A2/en not_active Application Discontinuation
- 2011-11-17 SG SG2013038344A patent/SG190829A1/en unknown
- 2011-11-17 JP JP2013540011A patent/JP6155193B2/en active Active
- 2011-11-17 CA CA2818308A patent/CA2818308A1/en not_active Abandoned
- 2011-11-17 US US13/988,251 patent/US9562038B2/en active Active
- 2011-11-17 AU AU2011329829A patent/AU2011329829B2/en active Active
- 2011-11-17 EP EP11842404.3A patent/EP2640720B1/en active Active
- 2011-11-17 CN CN201180065404.3A patent/CN103402998B/en active Active
- 2011-11-17 EA EA201390726A patent/EA201390726A1/en unknown
- 2011-11-17 KR KR1020137015098A patent/KR20140000275A/en not_active Application Discontinuation
- 2011-11-17 PE PE2013001206A patent/PE20140406A1/en not_active Application Discontinuation
- 2011-11-17 WO PCT/US2011/061174 patent/WO2012068366A2/en active Application Filing
- 2011-11-17 MX MX2013005462A patent/MX350974B/en active IP Right Grant
- 2011-11-17 CN CN201611167953.2A patent/CN107011333B/en active Active
-
2013
- 2013-05-16 IL IL226397A patent/IL226397B/en active IP Right Grant
- 2013-05-17 CL CL2013001429A patent/CL2013001429A1/en unknown
- 2013-06-07 CO CO13138546A patent/CO6801635A2/en not_active Application Discontinuation
-
2016
- 2016-11-04 JP JP2016215788A patent/JP6567486B2/en active Active
- 2016-12-15 US US15/379,969 patent/US10030008B2/en active Active
-
2018
- 2018-07-17 US US16/037,678 patent/US10703743B2/en active Active
-
2020
- 2020-06-05 US US16/894,362 patent/US11136316B2/en active Active
-
2021
- 2021-09-09 US US17/470,393 patent/US11858917B2/en active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL226397A0 (en) | Bifunctional molecules with antibody-recruiting and entry inhibitory activity against the human immunodeficiency virus | |
| IL252398A0 (en) | Cd37-binding molecules and immunoconjugates thereof | |
| IT1402653B1 (en) | PHOTOCATALYZING COMPOSITE AND PHOTOCATALYTIC FUNCTIONAL PRODUCT USING THE SAME. | |
| EP2799540A4 (en) | Human arginase and pegylated human arginase and application thereof | |
| EP2712384A4 (en) | Innovative cutting element and cutting structure using the same | |
| RS55927B1 (en) | Phenyl-3-aza-bicyclo[3.1.0]hex-3-yl-methanones and the use thereof as medicament | |
| HK1187527A1 (en) | N-carboxyalkyl auristatins and the use thereof | |
| ZA201209595B (en) | N-acetyl-dl-leucine, neuroprotective and retinoprotective medicament | |
| EP2771008A4 (en) | MACROCYCLES THAT INCREASE p53 ACTIVITY AND THE USES THEREOF | |
| IL222835A0 (en) | Bifunictional molecules for inactivating hiv and blocking hiv entry | |
| PL2855506T3 (en) | Peptide and the use thereof | |
| ZA201207416B (en) | Cdca5 peptides and vaccines including the same | |
| PT2563806E (en) | Human leukolectins and uses thereof | |
| EP2636737A4 (en) | Skin and hair color-controlling factor | |
| EP2515939A4 (en) | Photo-inactivated viruses and systems and methods of using the same | |
| EP2646546A4 (en) | Tomm34 peptides and vaccines including the same | |
| EP2659891A4 (en) | Drug with activity against the herpes virus family | |
| IL221474A0 (en) | Hjurp peptides and vaccines including the same | |
| GB201012941D0 (en) | Determining the extent of a structure on or in the skin of a subject | |
| IL225553A0 (en) | C180rf54 peptides and vaccines including the same | |
| IL225552A0 (en) | Wdhd1 peptides and vaccines including the same | |
| TWM390691U (en) | Caster device and luggage having the caster device | |
| PT2356993T (en) | Medicament for the reduction of cholesterolemia and/or triglyceridemia | |
| GB201015789D0 (en) | Peptides and their use in the treatment | |
| ZA201205434B (en) | Coffins, sarcophagi, cinerary urns and the like |